Press Releases
-
Press Release in relation to acquisition of ‘Razel’ franchise from Glenmark Pharmaceuticals Limited14.12.2022Read More
-
Q2 FY23 Press Release / News12.11.2022Read More
-
Q1 FY23 Press Release05.08.2022Read More
-
Q4 FY22 Press Release26.05.2022Read More
-
Q3 FY22 Press Release14.02.2022Read More
-
Press Release in relation to Acquisition of Brands and Related Assets from Sanzyme Private Limited27.01.2022Read More
-
Q2 FY22 Earnings Call Transcript17.11.2021Read More
-
Top stocks in focus: Tata Steel, RailTel, Indiabulls Housing Finance, ZEEL, JB Chemicals & Pharma15.11.2021Read More
-
JB Chemicals & Pharma reports Q2 PAT of Rs98cr up by 32% yoy; Stock trades in green15.11.2021Read More
-
BRIEF-India’s J B Chemicals And Pharmaceuticals Sept-Qtr Consol Net Profit Rises15.11.2021Read More
-
Tata Steel, Sun Pharma, Zee, NMDC and more: Top stocks to watch out for on Nov 1215.11.2021Read More
-
All you need to know going into trade on November 1215.11.2021Read More
-
JB Chem Q2 PAT up 32% YoY to Rs 98 crore15.11.2021Read More
-
Buzzing stocks: Coal India, Zee Entertainment, Tata Steel and other stocks in news today15.11.2021Read More
-
JB Chemicals Consolidated September 2021 Net Sales at Rs 593.01 crore, up 33.69% Y-o-Y15.11.2021Read More
-
JB Chemicals & Pharmaceuticals Q2 results: Net profit up 32% to Rs 98 cr15.11.2021Read More
-
India’s JB Chemicals and Pharmaceuticals Sept-Qtr Consol Net Profit Rises15.11.2021Read More
-
Business India Sept’21 Edition: JB Chemicals is all geared up to start its next growth phase!20.09.2021Read More
-
Q1 FY22 Results Sheet26.08.2021Read More
-
Disclosure of material event/information – Transcript of Earnings conference call – Q1 FY2219.08.2021Read More
-
Q2 FY21 Results Sheet17.08.2021Read More
-
Q1 FY21 Results Sheet17.08.2021Read More
-
Q1 FY 22 Earnings Conference Call Transcript13.08.2021Read More
-
Important communication with regard to TDS on dividend12.08.2021Read More
-
Presentation made to Investors – 12.08.202112.08.2021Read More
-
Disclosure of material event/information – Newspaper Advertisement11.08.2021Read More
-
Grant of Options under Employee Stock Option Scheme11.08.2021Read More
-
Board to consider and declare interim dividend for FY 2020-2103.08.2021Read More
-
Unaudited Financial Results 31.12.202003.08.2021Read More
-
Declaration of Interim Dividend03.08.2021Read More
-
Press Release for Unaudited Financial Results – 31.12.202003.08.2021Read More
-
Presentation made to Investors – 10.02.202103.08.2021Read More
-
Schedule of meeting with institutional investors03.08.2021Read More
-
Registration/ Log-in details for virtual call with management on 02.03.202103.08.2021Read More
-
Presentation made to Investors – 02.03.202103.08.2021Read More
-
Outcome of Board meeting03.08.2021Read More
-
Institution of new Employee Stock Option Scheme03.08.2021Read More
-
Launch of new dedicated division “RENOVA” to enter Nephrology segment in India03.08.2021Read More
-
Disclosure of receipt of requests from the promoters/ promoter group members seeking re-classification of status as public03.08.2021Read More
-
Notice of Board Meeting03.08.2021Read More
-
Recommendation of final dividend03.08.2021Read More
-
Schedule of Investors/ Analysts’ call with management on 15.06.2021 and Registration/Log-in details for the same03.08.2021Read More
-
Audited Financial Results 31.03.202103.08.2021Read More
-
Recommendation of Final Dividend for FY 2020-2103.08.2021Read More
-
Views of Board of Directors on the Reclassification Request03.08.2021Read More
-
Press Release for Audited Financial Results – 31.03.202103.08.2021Read More
-
Newspaper cutting of extract of Consolidated Financial Results 31.03.202103.08.2021Read More
-
Instructions03.08.2021Read More
-
Postal Ballot Form03.08.2021Read More
-
Postal Ballot Notice – 25.06.202103.08.2021Read More
-
Newspaper advertisement for Postal Ballot03.08.2021Read More
-
Results of Postal Ballot03.08.2021Read More
-
Disclosure of material event/information – Newspaper Advertisement23.07.2021Read More
-
Intimation of Record Date19.07.2021Read More
-
Postal Ballot Form19.07.2021Read More
-
Disclosure of material event/information – 02.07.202119.07.2021Read More
-
Notice of Annual general Meeting scheduled on September 9, 202119.07.2021Read More
-
Disclosure of material event/information – Change in Company Secretary & Compliance officer14.07.2021Read More
-
Newspaper advertisement for Postal Ballot03.07.2021Read More
-
Disclosure of material event/information – 02.07.202102.07.2021Read More
-
Press Release for Unaudited Financial Results – 30.06.202130.06.2021Read More
-
Q1 FY22 Earnings Call Audio30.06.2021Read More
-
Postal Ballot Notice – 25.06.202125.06.2021Read More
-
KKR-controlled drug maker JBCPL evaluating acquisition of select brands, mid-sized firm24.06.2021Read More
-
KKR-backed JB Chemicals scouting for acquisitions24.06.2021Read More
-
JB Chemicals Strong Run Of Growth Continues With International Rise23.06.2021Read More
-
Earnings Conference Call on Q1 FY 21-22 – Audio recording20.06.2021Read More
-
Q4 FY21 Earnings Call Transcript15.06.2021Read More
-
Newspaper cutting of extract of Consolidated Financial Results 31.03.202115.06.2021Read More
-
Presentation made to Investors – 14.06.202114.06.2021Read More
-
Recommendation of Final Dividend for FY 2020-2114.06.2021Read More
-
Newspaper advertisement for Book Closure / Record Date15.02.2021Read More
-
Disclosure of material event/ information – Appointment of Non-executive Director 10.02.202110.02.2021Read More
-
Disclosure of material event/ information – Resignation of a director 10.02.202110.02.2021Read More
-
Intimation of Record Date10.02.2021Read More
-
Newspaper cutting of extract of Consolidated Unaudited Financial Results 31.12.202031.12.2020Read More
-
Schedule of meeting with institutional investors – 16.12.202016.12.2020Read More
-
Newspaper Advertisement for Postal Ballot25.11.2020Read More
-
Result of Postal Ballot20.11.2020Read More
-
Disclosure of material event/ information – Appointment of auditors 10.11.202010.11.2020Read More
-
Disclosure of material event/ information – Resignation of auditors 10.11.202010.11.2020Read More
-
Disclosure of material event/ information – Resignation of a director 10.11.202010.11.2020Read More
-
Press Release for Unaudited Financial Results – 30.09.202010.11.2020Read More
-
Letter of offer for Open Offer16.10.2020Read More
-
Disclosure of material event/ information – Resignation of a director 05.10.202005.10.2020Read More
-
Appointment of Chief Executive Officer & Whole-time Director05.10.2020Read More
-
Announcement of Appointment of Mr. Nikhil Chopra as CEO05.10.2020Read More
-
Notice of Annual general Meeting scheduled on September 30, 202030.09.2020Read More
-
Newspaper Cutting of extract of consolidated Unaudited Financial Results 30.09.202030.09.2020Read More
-
Result of voting on the business transacted at the Annual General Meeting held on 30-09-202030.09.2020Read More
-
Notice of Annual General Meeting scheduled on September 24, 202024.09.2020Read More
-
Notice of Annual General meeting to be held on 30.09.2020 published in newspaper09.09.2020Read More
-
Intimation of Record date08.09.2020Read More
-
Advertisement for dispatch of Letter of offer05.09.2020Read More
-
Notice of Board Meeting05.09.2020Read More
-
Resignation of Independent Directors01.09.2020Read More
-
Change in Board of Directors31.08.2020Read More
-
Disclosure of material event/information – Purchase of Pharmaceutical Business Undertaking of Lekar Pharma Limited28.08.2020Read More
-
Disclosure of material event/information Open Offer by Tau Investment Holdings Pte. Ltd.-Extension of time for dispatch of Letter of Offer granted by SEBI28.08.2020Read More
-
Recommendation of Committee of Independent Directors (“IDC”) under Regulation 26(7) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011, as amended27.08.2020Read More
-
Notice of Annual General meeting published in news paper18.08.2020Read More
-
Prior Public Notice with regard to convening of AGM through Video Conferencing (VC)/Other Audio Visual Means (OAVM)14.08.2020Read More
-
Disclosure of material event/information – Demise of Chairman & Managing Director Shri Jyotindra B. Mody22.07.2020Read More
-
Purchase of Pharmaceutical Business Undertaking of Lekar Pharma Limited14.07.2020Read More
-
Disclosure of material event/information – Public Announcement of open offer02.07.2020Read More
-
Press Release for Unaudited Financial Results – 30.06.202030.06.2020Read More
-
Recommendation of Final Dividend for FY 2019-2025.06.2020Read More
-
Notice of Board Meeting11.06.2020Read More
-
ANDA approval by US FDA27.04.2020Read More
-
Postal Ballot Notice13.04.2020Read More
-
Disclosure of material event/information – Supreme Court judgement on orders passed by National Green Tribunal03.04.2020Read More
-
News about Ranitidine formulations in the US02.04.2020Read More
-
Annual Report of 2019-2020.03.2020Read More
-
Q4 FY20 Results Sheet03.03.2020Read More
-
Q3 FY20 Results Sheet03.03.2020Read More
-
Q1 FY20 Results Sheet03.03.2020Read More
-
Disclosure of material event/information –Institutional investors meet20.02.2020Read More
-
Board to consider and declare interim dividend for F.Y. 2019-2020.02.2020Read More
-
Declaration of Interim Dividend20.02.2020Read More
-
Intimation of Record Date20.02.2020Read More
-
US FDA approval of New Solid Oral dosage forms formulations manufacturing facility at Panoli, Gujarat11.02.2020Read More
-
Successful US FDA inspection of Solid Oral dosage forms formulations manufacturing facility at Panoli, Gujarat10.02.2020Read More
-
Acquisition of Trademarks04.02.2020Read More
-
Schedule of meeting with institutional investors 28.01.202028.01.2020Read More
-
Earnings Call28.01.2020Read More
-
Earnings Call28.01.2020Read More
-
Presentation made to Investors – 04.02.202031.12.2019Read More
-
J. B. Chemicals clears the confusion around Rantac® (Ranitidine)20.12.2019Read More
-
Regulatory one-time increase in price of Metronidazole Formulations16.12.2019Read More
-
Approval for re-classification of certain promoter group members to public28.11.2019Read More
-
Draft Letter of Offer for Buy-back of Equity Shares18.11.2019Read More
-
Public Announcement – Buy-back of shares13.11.2019Read More
-
Outcome of Board Meeting – Buy-back of Equity shares by the Company12.11.2019Read More
-
Intimation of Record Date for the proposed Buy-back of Equity shares by the Company12.11.2019Read More
-
Letter of Offer for Buy-back of Equity Shares12.11.2019Read More
-
Notice of Board Meeting – to consider & approve proposal for Buy-back06.11.2019Read More
-
Notice of Board Meeting04.10.2019Read More
-
News about presence of NDMA in Ranitidine30.09.2019Read More
-
Press Release for Unaudited Financial Results – 30.09.201930.09.2019Read More
-
Disclosure of material event/information – Resignation of a director – 30.09.201930.09.2019Read More
-
FY20 Strategy Presentation20.09.2019Read More
-
Disclosure of material event/information – September 12, 201912.09.2019Read More
-
Disclosure of material event/information – August 30, 201930.08.2019Read More
-
Disclosure of material event/information – August 28, 201928.08.2019Read More
-
Disclosure of material event/information – August 27, 201927.08.2019Read More
-
Result of voting on the business transacted at the Annual General Meeting held on 23-08-201923.08.2019Read More
-
Disclosure under Regulation 30 of SEBI (Listing Regulations and Disclosure Requirements), 2015 and Code for fair disclosure of UPSI15.07.2019Read More
-
Recommendation of Dividend for FY 2018-1921.05.2019Read More
-
Recommendation of Dividend08.05.2019Read More
-
Notice of Board Meeting April/05/201919.04.2019Read More
-
Press Release for Audited Financial Results – 31.03.201931.03.2019Read More
-
Q4 FY19 Results Sheet30.03.2019Read More
-
Notice of Board Meeting Jan/10/201910.02.2019Read More
-
Press Release for Unaudited Financial Results – 31.12.201709.02.2019Read More
-
Press Release for Unaudited Financial Results – 31.12.201831.12.2018Read More
-
Q3 FY19 Results Sheet31.12.2018Read More
-
ANDA approval by US FDA05.11.2018Read More
-
Update on disclosure of material event/information – November 5, 201805.11.2018Read More
-
Press Release for Unaudited Financial Results – 30.09.201802.11.2018Read More
-
Tender Form (demat shares)10.10.2018Read More
-
Tender Form (physical shares)10.10.2018Read More
-
Unaudited Financial Results 30.09.201830.09.2018Read More
-
Q2 FY19 Results Sheet30.09.2018Read More
-
Post buyback Public Announcement04.09.2018Read More
-
Notice of Annual General Meeting to be held on September 4, 201804.09.2018Read More
-
Result of voting on the business transacted at the Annual General Meeting held on 04-09-201804.09.2018Read More
-
Outcome of Board Meeting – Buy-back of Equity Shares by the Company31.08.2018Read More
-
Intimation of Record Date for the proposed Buy-back of equity shares by the Company31.08.2018Read More
-
Successful US FDA inspection of Solid Oral dosage forms formulations manufacturing facility at Panoli, Gujarat27.08.2018Read More
-
Notice of Board Meeting – to consider & approve proposal for Buy-back23.08.2018Read More
-
Public Announcement for Buy-back of Equity shares20.08.2018Read More
-
Share transfer Form (physical shares)20.08.2018Read More
-
Notice of Annual General Meeting published in Newspapers06.08.2018Read More
-
Change in dividend payment date02.08.2018Read More
-
Notice of Board Meeting25.07.2018Read More
-
Press Release for Unaudited Financial Results – 30.06.201830.06.2018Read More
-
Q1 FY19 Results Sheet30.06.2018Read More
-
Audited Financial Results 31.03.201828.05.2018Read More
-
Press Release for Audited Financial Results – 31.03.201825.05.2018Read More
-
Successful US FDA inspection of API Manufacturing facility at Panoli, Gujarat14.05.2018Read More
-
Board Meeting Intimation27.04.2018Read More
-
Disclosure of material event/information – April 24, 201824.04.2018Read More
-
Update on material event/ information – April 24, 201824.04.2018Read More
-
Disclosure of material event/ information – April 19,201819.04.2018Read More
-
Draft Letter of Offer for Buy-back of Equity Shares31.03.2018Read More
-
Letter of Offer31.03.2018Read More
-
Meeting with institutional investors23.02.2018Read More
-
Schedule of meeting with institutional investors21.02.2018Read More
-
Unadited Financial Results 31.12.201731.12.2017Read More
-
Notice of Board Meeting27.10.2017Read More
-
Q2 FY18 Results Sheet30.09.2017Read More
-
Press Release for Unaudited Financial Results – 30.09.201730.09.2017Read More
-
Notice of Annual General Meeting to be held on September 19, 201719.09.2017Read More
-
Result of voting on the business transacted at the Annual General Meeting held on 19-09-201719.09.2017Read More
-
Change in dividend payment date22.08.2017Read More
-
Public Announcement for Buy-back of Equity shares21.08.2017Read More
-
Share transfer Form (physical shares)21.08.2017Read More
-
Notice of Board Meeting27.07.2017Read More
-
Tender Form (physical shares)03.07.2017Read More
-
Tender Form (demat shares)03.07.2017Read More
-
Press Release for Unaudited Financial Results – 30.06.201730.06.2017Read More
-
Undited Financial Results 30.06.201703.06.2017Read More
-
Draft letter of offer for Buy-back of Equity shares02.06.2017Read More
-
Post Buy-back Public Advertisement02.06.2017Read More
-
Post Buy-back Public Advertisement24.05.2017Read More
-
Recommendation of Dividend for the F.Y.2016-1723.05.2017Read More
-
Intimation of Record Date for the proposed Buy-back of shares23.05.2017Read More
-
Buy-back of Equity Shares23.05.2017Read More
-
Board of Directors to consider the proposal for Buy-back of equity shares17.05.2017Read More
-
Notice of Board Meeting04.05.2017Read More
-
Recommendation of Dividend04.05.2017Read More
-
Audited Financial Results 31.03.201731.03.2017Read More
-
Press Release for Audited Financial Results – 31.03.201731.03.2017Read More
-
Press Release for Audited Financial Results – 31.03.201731.03.2017Read More
-
Unaudited Financial Results 31.12.201610.02.2017Read More
-
Notice of Board Meeting25.01.2017Read More
-
Resignation of a director – Dr. Niranjan Maniar23.11.2016Read More
-
Notice of Board Meeting04.10.2016Read More
-
Q2 FY17 Results Sheet30.09.2016Read More
-
Press Release for Unaudited Financial Results – 30.09.201630.09.2016Read More
-
Resignation of a director – Mr. Jashvantrai Joshi29.09.2016Read More
-
Notice of Annual General Meeting to be held on August 23, 201623.08.2016Read More
-
Result of voting on the business transacted at the Annual General Meeting held on 23-08-201623.08.2016Read More
-
Notice of Board Meeting22.07.2016Read More
-
Update on material event/ information – 18 July 201618.07.2016Read More
-
Q1 FY17 Results Sheet30.06.2016Read More
-
Press Release for Unaudited Financial Results – 30.06.201630.06.2016Read More
-
Recommendation of Final Dividend20.05.2016Read More
-
Update on material event/ information – 19 May 201619.05.2016Read More
-
Notice of Board Meeting20.04.2016Read More
-
Update on material event/ information – 31 March 201631.03.2016Read More
-
Press Release for Audited Financial Results – 31.03.201631.03.2016Read More
-
Update on material event/ information – 29 March 201629.03.2016Read More
-
Resignation of a director – Mr. Mahesh K. Shroff11.03.2016Read More
-
Update on material event/ information – 11 March 201611.03.2016Read More
-
Declaration of Interim Dividend11.03.2016Read More
-
Update on material event/ information – 4 March 201604.03.2016Read More
-
Update on material event/ information – 9 February 201609.02.2016Read More
-
Notice of Board Meeting03.02.2016Read More
-
Appointment of Independent director- Mr. Shaukat Merchant03.02.2016Read More
-
Disclosure of material event / information13.01.2016Read More
-
Unaudited Financial Results 31.12.201531.12.2015Read More
-
Press Release for Unaudited Financial Results – 31.12.201531.12.2015Read More
-
Information under clause 36 of the Listing Agreement05.11.2015Read More
-
Unaudited financial results 30.09.201530.09.2015Read More
-
Press Release for Unaudited Financial Results – 30.09.201509.09.2015Read More
-
Notice of Annual General Meeting to be held on August 19, 201519.08.2015Read More
-
Results of voting on the business transacted at the Annual General Meeting held on 19.08.201518.08.2015Read More
-
Recommendation of Special dividend and regular dividend13.08.2015Read More
-
Intimation of change in dividend payment date09.07.2015Read More
-
Intimation of Book Closure09.07.2015Read More
-
Unaudited Financial Results 30.06.201530.06.2015Read More
-
Press Release for Unaudited Financial Results – 30.06.201530.06.2015Read More
-
Notice of Board Meeting30.06.2015Read More
-
Audited Financial Results 2014 -1520.05.2015Read More
-
Press Release for Audited Financial Results – 2014-1520.05.2015Read More
-
Notice of Board Meeting05.05.2015Read More
-
Business India Sept’21 Edition: JB Chemicals is all geared up to start its next growth phase!20.09.2021Read More
-
Leader Speaks – Interview with Mr. Nirav Mody on October India Infoline12.08.2021Read More
-
JB Chemicals & Pharmaceuticals seeks to expand market for prescription lozenges with new launches16.06.2021Read More
-
KKR-owned JBCPL to aggressively scale up, acquire local drug brands12.02.2021Read More
-
KKR-backed JB Chemicals scouts for acquisitions, plans to revamp business08.02.2021Read More
-
J. B. Chemicals in the Forbes Global list of best under $1 billion in Asia Pacific11.01.2004Read More